Home    About Us    Medic-All    Bio B2B    Hot Topic     Expo     Login | Join Now          

SB04

SB04

A conventional drug in new use to treat dry-AMD (dry Age-related Macular Degeneration). Phase II/III clinical trial has been conducting in US and Taiwan.

Request for Collaboration
Overview
SB04 is a conventional drug in new use to treat patients with dry AMD. SB04 has many different mechanisms to treat patients without invasive way; even patient self-applied medication.
 
  • Eye drop formulation
  • 505(b)(2) regulatory pathway
  • Fast Track Pathway for IND in Phase II/III
  • Phase II/III clinical trial is ongoing in the US and Taiwan.
Application
Potential indication:

Dry-AMD (Dry Age-related Macular Degeneration)
Collaboration Options
  • Co-develop
  • Licensing
People who like this also like
  • LT1001LT1001
  • Zelnite®Zelnite®
  • PHN015 (Hemorrhage stroke)PHN015 (Hemorrhage stroke)
  • Dynamic Auto-FocusingDynamic Auto-Focusing
  • AmCAD CAAmCAD CA
  • Small Molecule DrugsSmall Molecule Drugs
  • TLC599TLC599
  • Medical Image Processing Apparatus and Breast Image Processing Method ThereofMedical Image Processing Apparatus and Breast Image Processing Method Thereof
  • PEP503 (A Radio-enhancer)PEP503 (A Radio-enhancer)
  • low-alcohol formulation (iLEF) platformlow-alcohol formulation (iLEF) platform